Catalyst Wire Dossier Catalyst Wire Dossier

Quadrivalent inactivated influenza vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quadrivalent inactivated influenza vaccine, covering 2024-01-25 to 2024-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects. [Phase 2]

See pricing